5paisa Capital Finalizes ₹468.8 Crore Rights Issue for 2026

Introduction

5paisa Capital Limited has announced the definitive terms for its upcoming rights issue, following a board meeting on March 11, 2026. The company aims to raise ₹4,688.23 million (₹468.8 crore) by offering equity shares to its existing shareholders. This capital infusion is intended to strengthen the company's financial position and support its operational requirements. The issue is priced at ₹300 per share, with a record date set for March 17, 2026, to determine shareholder eligibility.

Background of the Capital Raise

The decision to finalize the rights issue terms comes after the company's board initially approved a fundraising plan of up to ₹4,750 million (₹475 crore) on February 24, 2026. At that time, a Rights Issue Committee was formed to determine the specific details of the offering, including the price, entitlement ratio, and timeline. The March 11 meeting concluded this process, establishing a clear framework for the capital raise and providing certainty to investors regarding the structure and schedule of the issue.

Detailed Rights Issue Terms

The board has structured the rights issue to provide an opportunity for existing shareholders to increase their stake in the company. The issue price of ₹300 per share includes a premium of ₹290 over the face value of ₹10 per share. The entitlement ratio ensures a proportional offering to all eligible investors.

Key Dates and Timeline

A clear timeline has been established for the rights issue process. The record date is crucial for determining which shareholders are eligible to participate. The issue will open for subscription on March 27, 2026, and close on April 10, 2026, with a window for on-market renunciation of rights entitlements.

Impact on Share Capital

Assuming full subscription, the rights issue will significantly expand 5paisa Capital's equity base. The number of outstanding equity shares will increase from 31,254,838 to 46,882,257. This 50% increase in the number of shares reflects the substantial nature of the capital infusion, which is expected to enhance the company's net worth and provide capital for growth and operational stability.

Use of Proceeds

The net proceeds from the rights issue are earmarked for specific corporate purposes. According to company disclosures related to the fundraising plan, the capital will be used to augment funds for maintaining margin deposits with stock exchanges, amounting to approximately ₹227 million. An additional ₹150 million is intended for the repayment or prepayment of certain outstanding borrowings, which will help deleverage the balance sheet. The remaining funds will be allocated for general corporate purposes.

Market Context and Stock Performance

The announcement of the rights issue comes at a time when the company's stock has seen volatility. While the initial news of a potential rights issue on February 24 was met with a positive market response, the stock has faced downward pressure in the recent past. A look at the historical returns provides context for its performance.

This performance backdrop highlights the importance of the capital raise in stabilizing the company's financial footing and potentially improving investor confidence in its long-term strategy.

Regulatory Approvals

5paisa Capital has secured the necessary regulatory clearances for the rights issue. The company received in-principle approvals from both the BSE Limited and the National Stock Exchange of India Limited (NSE) on March 5, 2026. The entire process is being conducted in compliance with the Companies Act, 2013, and regulations set forth by the Securities and Exchange Board of India (SEBI).

Conclusion

5paisa Capital has laid out a clear and detailed plan for its ₹468.8 crore rights issue. With the price, ratio, and timeline now finalized, the focus shifts to the execution of the offering. The successful completion of the issue will provide the company with significant capital to strengthen its balance sheet, reduce debt, and fund its operational needs. For investors, the key element to monitor will be the subscription levels during the issue period, which will indicate shareholder confidence in the company's future prospects.